Enliven Therapeutics, Inc. (ELVN)
38.83
+1.04
(+2.75%)
USD |
NASDAQ |
Apr 02, 16:00
38.72
-0.11
(-0.28%)
After-Hours: 20:00
Enliven Therapeutics EPS Diluted (Quarterly) : -0.4769 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Sarepta Therapeutics, Inc. | -3.934 |
| Coherus Oncology, Inc. | -0.3097 |
| Kodiak Sciences, Inc. | -1.042 |
| Allogene Therapeutics, Inc. | -0.1717 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.67M |
| Total Expenses (Quarterly) | 29.67M |
| Enterprise Value | 1.860B |
| Earnings Yield | -4.67% |
| Normalized Earnings Yield | -4.670 |